(listed alphabetically by last name – click on name for full profile)
San Francisco, United States
This is a unique moment to address the global burden of cancer. Political will is high, with the Sustainable Development Goals and the Noncommunicable Diseases targets rising to the top of the health agenda. And more than ever we are aware of the global inequities in cancer care, prevention, survivorship and palliative care within and between countries. As we increasingly understand the social determinants of health, we can advocate for a holistic approach in care and in policy. UICC is well positioned to play a significant role in informing the global cancer agenda. It is an exciting opportunity for people like me, who spent over 3 decades in cancer care and control, to engage as part of the UICC Board of Directors and bring a voice for nursing, for cancer prevention and for building health capacity and leadership. I am looking forward to support C/Can 2025 where I can add my experience working with multiple sectors of government in LMICs, particularly in Africa, Latina America and South East Asia.
UICC is continuing to evolve and innovate. I have the honour of having been recognized for my work by WHO and others, and to have the full support from my peers as I seek a role on the Board. Being on the Board of Directors will give myself, together with my fellow Board Members, and UICC team, the opportunity to contribute to bringing real and lasting change to ensure that cancer care and control is one that I would value tremendously and would commit to wholeheartedly.
I will add to the Board’s mix of experiences and skills. I was born, went to college and started working in Brazil. I also experienced education in the USA, where I now live. Studying and working in two very different settings gave me an appreciation for high standards of care and for providing evidence-based care with few resources. I have the honour of being part of international cancer nursing since 1991 through the International Society of Nurses in Cancer Care, most recently as its President (2014-18). I am committed to ensure that nurses, the largest group of healthcare professionals worldwide, and nursing organisations enhance their engagement in cancer care and control. Globally, most cancer patients do not have access to specialised nursing care.
Specialty care is a goal, but we need to ensure that nurses in various settings are prepared to care for cancer patients. I have decades of involvement in international tobacco control, especially the development and implementation of the WHO Framework Convention on Tobacco Control. I have worked with WHO and the Convention Secretariat since 1999, gaining a great experience in international health diplomacy, providing technical assistance to governments and all of WHO Regions. I remain committed to saving lives through tobacco control. My networking skills are facilitated by fluency in four languages. I will bring to the board a depth of knowledge and commitment to address the tobacco and cancer-global burden of disease.
Ever increasing rate of cancer especially among children around the world highlights deficiencies such as lack of expertise and facilities or inefficient policy making systems particularly in low and middle income countries, while NGOs have proved their invaluable impact on improving access to cancer diagnosis and treatment services.
Hence, more participatory approach to planning impactful approaches for advocacy to raise awareness, and implementing more applicable cancer control campaigns by considering other relevant factors like cultural norms and beliefs along with real infrastructural and capacity restrictions are required.
Having constructive access to 110 haematologist-oncologists around the country for the past decade as MAHAK CEO, I have contributed as core participatory actions to forging effective coalitions, developing equity-based organisational capacities, shaping public legitimacy, and bridging gaps between health care professionals, psycho-social support mechanisms, public policy makers, international agencies, and societal stakeholders. These experiences and traits are transferable to UICC, the forum for influencing paediatric cancer care globally.
Since childhood cancer has been neglected comparing to the attention given to cancers in adults, as a manager who is leading one of the best of its kind centres in the region I would take the lead in UICC to pay more attention to this issue in formulating and implementing child-centric cancer control policies.
Since 2008, I have been the CEO of MAHAK, the 26-year old Society to Support Children Suffering from Cancer in Iran where, as a non-medical expert managing one of the largest hospitals and charity organizations, I have acquired a great overview on formation of policies and actions in developing countries.
As the CEO, I have augmented the prestige of MAHAK in the international arena by advocating and planning a multidisciplinary treatment approach born from our extensive experience in paediatric cancer. I have also overseen our ongoing advisory role at ECOSOC and partnership with UNHCR.
As the chair of the B.o.D of Iranian National Network of Cancer, I have gathered 37 NGOs to effectively communicate with the Ministry of Health and Medical Education to have more impact on related policy developments in Iran.
Regarding resource mobilization, by developing sustainable resource supply system reliant exclusively on public sources, MAHAK’s income increased 23% from €53,000,000 in 2015 to €65,000,000 in 2016 achieving for the first time the capacity to cover 100% of the supportive and treatment expenses for children with cancer.
I believe my experiences and passion to promote comprehensive and integrated services for children with cancer and their families can contribute to UICC to identify new strategies for advocacy, raising awareness within the society and engaging stakeholders to create the best circumstances for our patients presently and for the foreseeable future.
This is an incredibly exciting time in oncology. New treatments and technologies are allowing us to cure patients we never thought we’d be able to cure. Vaccination and screening advances mean that we’re starting to see an actual decrease in the incidence of some cancers in high income countries. But not everyone is benefitting the same. Some people are being left behind both within countries and among countries. As an oncologist who is also involved in national policy development and implementation, I find UICC’s mission to advocate for initiatives that will decrease the global burden of cancer personally compelling. I want to channel my abilities into helping UICC set its strategic directions and realize this mission. Through exchange of knowledge and experiences with international colleagues I hope to strengthen the ties between Canada and the international oncology community. The world needs a strong and effective UICC. I would like to help with that.
I am a practicing medical oncologist, a health services researcher, and Vice-President of Cancer Control at the Canadian Partnership Against Cancer (CPAC). CPAC, like UICC, engages with and convenes a wide range of partners to accelerate and drive excellence in cancer care delivery, with a large focus on equity. This work requires skills in engaging patients, health ministries, experts, and cancer control leaders, along with deep knowledge and expertise in cancer control. Similar skills are needed within the UICC. In addition, my career has been split between Canada’s public health care system and the largely private one in the United States. Consequently, I will bring to the Board important insights and a unique perspective as a clinician, researcher, and systems-level thinker. I have held executive-level positions with Cancer Care Ontario and the Ontario Institute for Cancer Research over the past 10 years, and I have prior relevant governance experience, having served on the Board of Directors of the Canadian Breast Cancer Foundation, BioCanRx (a public-private partnership developing immunotherapies), and of the Canadian Cancer Research Alliance. I believe that my background can be put to good service as a Board member, continuing to move UICC forward in its quest to decrease the global burden of cancer.
I am heavily involved in national, regional and international cancer awareness, prevention, early detection, management & support of cancer patients & survivors, professional education, policy making, and promoting cancer control in Lebanon, Arab Countries and worldwide. My clinical, research, professional and public service experience with over 120 publications and books, hundreds of public appearances on cancer epidemiology, prevention and management would be at service of UICC and global efforts to curb global cancer burden, reduce disparities in outcome, and improve survival & quality of life worldwide, and advance UICC vision, innovate cancer control in High and LMIC, large cities, rural areas, as well as underserved populations in HIC, intensifying fight against cigarette & hookah smoking amongst young people worldwide, improve promotion and access to HPV & HBV vaccinations, screening and early detection, fight myths and misconceptions about cancer, improve data collection and registries, reduce disparities in access to diagnosis & care, make surgery, radiation and making new effective medications available & more accessible, pain control, advocate for patients’ rights and survivors, improving education & training, working with policy makers, medical centers, universities, public figures and philanthropic leaders, investment in health infrastructure, international collaboration, better transfer of knowledge and experience, and implementation of recommendations worldwide.
My personal education, training, knowledge, experience & leadership roles. As in my CV, I grew up in Beirut, graduated from Brussels, trained in New York, practiced in New York, Riyadh, Detroit and now Beirut. I am Founding President of Lebanese Society of Medical Oncology (LSMO), chaired ASCO International Committee, co-Chaired ASCO Guidelines Advisory Group for Resource-Stratified Guidelines, serve as member of several ASCO, ESMO, UICC, WHO, ESO Committees, co-author of ESO/ESMO ABC International Consensus Guidelines for Advanced Breast Cancer, ESMO/ASCO Global Curriculum for Medical Oncology Training, BHGI Guidelines, launched ASCO Resource-Stratified Guidelines, was nominated for ASCO Board of Directors, Lebanese Breast Cancer Committee Ministry of Health, President Lebanese Breast Cancer Foundation, Board member Arab American Medical Association, UICC SPARC Metastatic Breast Cancer Challenge Grants, UICC Essential Medications List & Book Chapter on Metastatic Breast Cancer, February 4th World Cancer Day activities, WHO Task Forces & Committee meetings in Cairo & Geneva. My research, teaching, patient care, advocacy, professional and community activities are recognised to have led to significant regional & international impact & downstaging of breast cancer in Lebanon & improvement of patient outcome for which I received Medals of Honor from the Presidents of Lebanon, League of Lebanese Woman’s Rights, Cairo University, Fellowship of ASCO Award 2018 & others.
New York, United States
I strongly believe in the vision and mission of UICC. UICC is unparalleled as a truly global civil society organisation dedicated to improving access to cancer care and control for all. UICC is unique in its capacity to unite the cancer community in these efforts, comprising a diverse membership and a community of advocates not limited to any region, country income level, or discipline. Its growing influence is helping to integrate cancer control into the global health and development agenda. While I was a Medical Officer at WHO I worked closely with UICC in joint advocacy efforts, including the development of the 2017 Cancer Resolution. At the 2016 World Cancer Congress we launched The Lancet Series: "Health, equity, and women's cancers" with more than 40 authors from 18 countries. In Kuala Lumpur this October I greatly look forward to joining colleagues from all over the world and will serve as chair or speaker in four WCC 2018 sessions including those organised by IARC and the U.S. NCI Center for Global Health. I enjoy serving as an expert advisor to regional and global UICC campaigns and events including the new "Treatment for All Campaign". In May 2018 I spoke on behalf of UICC at a United Nations member states briefing to prepare for the next High-Level Meeting on NCDs at the 2018 UN General Assembly. I wish to serve on the UICC Board of Directors to dedicate more time and effort in pursing our common mission, to reduce the burden and impact of cancer globally.
I am a medical oncologist with expertise in cancer prevention, early detection, and global public health. I have dedicated much of the last 15 years to global cancer control research, education, and policy, working with colleagues on five continents. I am advisor to Vietnam's National Institute for Cancer Control and an adjunct faculty member at BRAC University's School of Public Health in Bangladesh. In 2015-2016 I was a Medical Officer at WHO, where I provided assistance to member states and represented the agency on the Secretariat for the UN Joint Programme for Cervical Cancer Prevention and Control. Now based at New York University as Director of Cancer Genetics and Associate Professor of Population Health and Medicine, I continue to work with WHO, IARC, and IAEA, and have recently participated on missions to Sudan, Indonesia, and Myanmar. Just prior to the 2018 World Health Assembly, I spoke at the Third Annual Ministerial Roundtable, "Cervical Cancer: and NCD we can overcome" with leadership from UICC, World Bank, U.S. NCI, GAVI, and the Global Fund. I am very active on social media and use these platforms to promote the work of UICC in cancer advocacy efforts. I believe I have a unique combination of skills and experience to serve the mission of UICC. I am passionate about making substantive contributions to the organisation, and if I am fortunate enough to be elected I will be a highly engaged and effective member of the UICC Board of Directors.
Seattle, United States
I am committed to improving cancer outcomes at a global level. Throughout my oncology career I have supported cancer patient advocacy, creating opportunities for partnerships between patients, health care providers, and policy-makers. I have led international efforts in cancer education, advocacy and outreach, founding the Women's Empowerment Cancer Advocacy Network (WE CAN) to further this mission. I have promoted health professional training and capacity-building, serving as a senior advisory member of the Uganda Cancer Institute Hematology-Oncology Fellowship program. I am committed to improving the quality of life of cancer patients through healthy lifestyles, founding Team Survivor Northwest, a non-profit aimed at helping female cancer survivors improve their health through fitness and exercise. I regularly participate in UICC World Cancer Congresses and World Cancer Day activities, and am aware of the important role UICC plays on the global stage. I have served as a collaborator and mentor for UICC SPARC grant recipients, and helped create a UICC Master Course in metastatic breast cancer. My passion for empowering patient advocates is in excellent alignment with UICC’s mission. My strong relationships within the global oncology community and my expertise in cancer care and clinical trials can serve as assets to UICC. I believe that serving on the UICC Board of Directors would allow me to contribute on an even larger scale to improving cancer outcomes globally.
I am Professor of Medical Oncology/Global Health at the University of Washington and Fred Hutchinson Cancer Research Center, with a commitment to empowering patient advocates and addressing health disparities. I have diverse experience in global oncology that could provide expertise to UICC. I work closely with patient advocates through the Women’s Empowerment Cancer Advocacy Network and serve in professional advisory capacity for cancer advocacy NGOs across the world. I have on-the-ground experience with cancer care in limited resource settings as a member of the Fred Hutch-Uganda Cancer Institute collaboration. As an expert in cancer clinical research, I am a strong advocate for evidence and innovation in improving cancer diagnosis and treatment. As a member of the Global Task Force on Expanded Access to Cancer Care and Control, I gained perspective on the roles of health systems and health policy in cancer control. Through volunteer activities in oncology professional societies, I have forged relationships with colleagues across the globe. I chair ASCO’s Academic Global Oncology Task Force, served on ASCO’s International Affairs Committee, and am co-chair of ASCO’s Resource Stratified Guideline Group. I have experience coordinating summits, gaining consensus, and leading global campaigns, co-chairing Breast Health Global Initiative resource-stratified guideline summits, and Breast Cancer Initiative 2.5 - a global campaign to reduce disparities in breast cancer outcomes.
As a President of French African Pediatric Oncology Group (GFAOP), I have with my group contributed in building capacity and providing support to almost all French speaking African countries. We have also been able to put in place African School of Pediatric Oncology with the contribution of University Mohammed V in Rabat in Morocco and Paris-Sud in France. We are also putting in Place the Institute Jean Lemerle with University of Dakar. Beside this our group is contributing in providing medication and supplies for paediatric oncology paediatric pilot units. This experience that started since 2000, initiated by a French paediatric oncologist (Pr Jean Lemerle) is considered a success because of capacity of mobilisation and also because it integrated support, capacity building and clinical research and publications. More than 1000 new children are treated in the GFAOP network. In a continent with tremendous needs this maybe a model for development of cancer care in general. In my country I have also worked in developing care through a national paediatric cancer society with various adapted approaches. I have been participating as a Board member in UICC and have been able to contribute to its activity. I believe that UICC can contribute efficiently in limited resources and particularly in Africa.
UICC is recognised as a key actor in cancer control at a global level. It is now having more ambitious role in developing successful models. C-Can programme is one of the models that should make direct impact in cities in developing countries. In Africa, cancer care is not considered as priority by most African stakeholders. UICC may play efficient role in capacity building and gathering resources as it is already the case in particular in capacity building. Comprehensive approaches and developing networks are needed for more efficiency. The experience of GFAOP in putting in place childhood cancer care in French speaking African countries may help.
Cancer incidence rate is going to rise worldwide specially in developing countries. I have had the honour to serve a first term (2016-2018) as a member of the UICC Board of Directors. If I have the chance for a second term, I would continue to support and align with the current plans in achieving UICC objectives to reduce the global cancer burden, promote greater equity for every cancer patient to have a better medical care, and integrate cancer control into the world health agenda. This would be done through supporting ongoing activities related to city cancer challenge, basic and human capacity building, universal availability of effective pain medication, dispelling myths and misconceptions about cancer, and delivering the targets of the World Cancer Declaration.
Examples of my activities during the first term as UICC Board member expressing full engagement include active participation on the Membership Committee to support the ambition to grow and engage UICC membership, be part of the UICC strategic review process that sets the organisational ambitions for 2030, participation on key convening events such as World Cancer Day (by attending many national and regional events),World Cancer Leaders' Summit and World Cancer Congress, ensuring the voice of the region to be represented at the highest level at UICC, e.g. discussing the economic burden of new treatments on health systems, and getting more experience on how UICC is governed and working.
I am a professor of medical oncology at the National Cancer Institute, Cairo University. In 2002 I served as the dean of this comprehensive institute for six years. Thereafter, I was appointed Vice President of Cairo University (2008 – 2011) and then Minister of higher education of Egypt (2012). I have been engaged in many cancer control activities on a national level, such as secretary general of the Egyptian foundation for cancer research, head of the council of the Egyptian medical oncology fellowship, and the Editor-in-Chief of journal of advanced research (the official journal of Cairo University).
Regionally and internationally, I served as the Assistant Secretary General of the Arab Medical Association Against Cancer for four years, the national representative of ESMO for Egypt and North Africa (2000-2006), and I am also a member of many international societies including ESMO, ASCO, and the lymphoma group in the EORTC. I was also a member of the editorial board of the Annals of Oncology (2006-2012).
My research activities are focussed mainly on bladder cancer, breast cancer, and malignant lymphomas, with more than 150 national and international publications (total impact factor of 500; total citations of >3000, and h-index of 27 as of May, 2018).
Having more than 30 years’ experience in cancer control at local state national and international level I would like to offer my expertise to the strategic decision making body for UICC.
Joining the Board is an opportunity for me to improve international efforts on mission and achieving the greatest possible progress in cancer control, with a particular focus on achieving progress in low and middle-income countries. Enormous opportunities in prevention and early detection of cancer and all NCDs exist, particularly now with developments in the international arena in NCD prevention, if existing learnings are applied internationally.
As a current Board member of a Health Promotion agency and CEO of a national organisation focussed on public health, along with governance training through the Australian Institute of Company Directors, and 24 years working in a Cancer Control organisation, I can bring an important range of experience to the deliberations of the UICC Board.
I also hold Adjunct Professorial appointments at two universities and have research experience which will assist in contributing to evidence based decision making at board level.
I believe Board leadership should come from a close understanding of the mission of the agency. I am confident I can bring that to a leadership role at UICC and would welcome the chance to serve this vital international effort.
Adjunct Professor Terry Slevin has been involved with UICC for more than a decade contributing to planning for the past four World Cancer Congresses.
He has served as Co-Chair of the Scientific Program Committee for WCC 2018.
He led the creation of the 2009 World Cancer Day Report on childhood obesity and have contributed to workshops and capacity building within the cancer control community for more than 2 decades. He has advised UICC on issues such as obesity, alcohol and asbestos.
He has leadership credentials in cancer and non cancer organisations, governance training, international cancer control expertise across a range of issues from tobacco, skin cancer, nutrition, obesity, screening and advocacy.
Terry is passionate about sharing expertise and ensuring knowledge transfer to maximise efficiency in investment of cancer control resources to ensure the best outcomes. He has a long history of successful financial and people management and has built up strong networks internationally in cancer control.
He has supported the development and training of cancer control young professionals and focussed on supporting low and middle-income countries best develop and advance cancer control policy and practice.
Most importantly Terry is committed to the success and ambitions of UICC as a world leader in cancer control.
And as you can see from the photo, he likes to laugh.
I would like to be on the UICC Board of directors because I think that with my experience I can contribute to promote cancer control among countries, to promote the implementation of strategies for cancer prevention, early detection, to reduce inequities to cancer treatment technologies and to promote access to palliative care.
As long as I participated in the initiative of the UICC C / Can 2025, specifically in the implementation of the process in Cali, I would like to contribute and participating with other countries.
I have 20 years of experience in national and international activities for cancer control. As a researcher and as a public health worker I mainly contributed with the tobacco control and with the evaluation and implementation of cervical cancer strategies such as screening and vaccination programs.
I have been the General Director of the National Cancer Institute of Colombia, one of the oldest National Cancer Institutes in Latin America for almost 4 years. I worked, in coordination with the Ministry of Health promoting comprehensive cancer control. I also participated in the formulation and monitoring of the National Cancer Plan of Colombia 2012-2022.
My relationships with key international agencies such as WHO/PAHO, IARC and networks as RINC, can be a key factor in order to contribute to UICC objectives.
The incidence of cancer is increasing globally and WHO predictions are of a rapidly changing landscape with a projection that two thirds of cases will be from the developing world within the next two decades. The problem is further compounded by the fact that of the premature cancer deaths worldwide, two thirds occur in low- and middle-income countries (LMICs), the majority of which lack proper infrastructure and resources.
There is therefore a well-recognised need for action and promoting greater equity in these resource-limited settings.
Much also needs to be done in the developed world where numerous issues hamper the progress in cancer control. These range from rising cost of cancer care, geographic distribution of service issues, socioeconomic inequalities, in addition to the growing epidemic of obesity as a major cause for cancer. Other global issues to be addressed are the implementation of HPV and HBV vaccinations, cancer drug pricing, availability of healthcare, human resources and healthcare systems infrastructure.
Civil society must engage in addressing these issues.
UICC is the ideal organisation to convene the voice of civil society with its membership including diverse groups of organisations with a reach of over 150 countries. In addition, UICC has strategic alliances with other major stakeholders, namely the NCD Alliance, WHO, IARC and IAEA, which help integrate cancer control into the world health and developmental agenda.
The expansive reach, the impact and the great potential of UICC has been more apparent over the last six years, and as a member of the Board of Directors, I had many opportunities to witness the impact that our organisation has on global cancer control and to contribute to the development of the strategy and long-term goals for UICC. Being an integral part of two strategy planning meetings of the UICC has helped me contribute to the road map that the organisation will take over the next decade. As President, I will therefore be ideally suited to shape this vision and contribute along with the Board of Directors and the Geneva team towards this effort.
Personally, I have been engaged in the cause of cancer control at the national level in India as an oncologist, researcher and administrator and globally as a leader in head and neck cancers. These multiple roles place me at an advantage in understanding the intricacies of the problem, a profound understanding of the role that research science must play in cancer control, identify priority areas that need attention and the potential solutions that need to be worked on.
Having the opportunity to lead UICC will help consolidate my current efforts as well as give new direction towards reducing the cancer burden globally.
Lastly, it is time for the leadership of UICC to come from the area with the largest population and largest cancer burden, where the majority of the World Cancer Declaration targets need to be addressed. In addition, encouragement from the majority of member organisations and global leaders in cancer control motivates me to resubmit my nomination yet again.
I have been actively involved and possess a strong knowledge of the working and the mission of UICC having served on the Board of Directors for the last four years. The purpose statement of UICC was drafted during this time and I was actively involved in this process.
I have also served on many of the pivotal committees of the Board, namely the Governance, Finance, Membership, Congress and World Cancer Leaders’ Summit. I have had the privilege to lead the Paris 2016 World Cancer Congress as well as the 2018 Kuala Lumpur Congress as co-chair. In addition, I have been editor of the recently published UICC Manual of Clinical Oncology as well as serve as a member of the literature watch committee of the UICC TNM.
With thirty years’ experience as an oncologist, researcher and administrator in the field of cancer control, I have been Director at Tata Memorial Hospital in Mumbai, India – the largest and one of the oldest comprehensive cancer centres. The hospital is considered a leader not only in the country, but also in the region for cancer control activities and policy. It has had a close association with UICC since its inception and hosted the UICC World Congress in 1994.
I hold numerous leadership positions both nationally and internationally on board of directors, governing councils and executive committees of various hospitals, research centres, governmental organisations, cancer care organisations, advocacy group and professional bodies.
Having delivered over 350 lectures, keynote addresses and orations around the world, I am comfortable speaking and interacting at the highest levels. I have a strong scientific background, having authored over 200 peer-reviewed publications. This unique position of being a clinician, researcher, administrator and a leader gives me the advantage of bringing the right blend of science and action into the fight on cancer control.
The prime area of my focus would be towards consolidating efforts to achieve the World Cancer Declaration targets.
Top of the list of priorities would be – tobacco control advocacy which still is a major issue worldwide, more so in LMICs. In addition, efforts towards control of cervical cancer responding to the recent call of the WHO director general would be high on my agenda.
I would make efforts to unite the cancer community by enrolling more members as well as ensuring that current members are more engaged in the activities of UICC. Efforts will be made to broaden our relationships with other cancer and non-cancer related partners. I also believe that engaging potential young leaders would be the right step towards ensuring the continuity of cancer control in the years to come.
I will strive to put objective criteria in monitoring our progress towards the implementation of the World Cancer Declaration targets. In addition, as part of this effort, I shall try to develop implementation tools that are adaptable at different levels and across different regions of the world.
As part of the ‘C/Can 2025’ Task Force, I will build and take this latest initiative to completion. C/Can 2025 is a new initiative of UICC, focussed on putting together a total cancer solution for cities globally. Initially targeted at five cities, the final plan is to impact 500 cities worldwide. There is so much to do, but space constraints restrict me from listing all. Let’s walk together to make a difference in our efforts towards global cancer control.
The information contained in each of the candidates' profile has been provided by the candidates themselves, and it is intended exclusively for the UICC members voting at the elections for the UICC Board of Directors and President-elect. UICC's role is limited to providing the platform for the candidates to share their information and views. The views expressed by the candidates are not those of UICC. Any use, disclosure or unauthorised reproduction of this information is prohibited.